Ovarian Endometrioid Adenocarcinoma Active Not Recruiting Phase 2 Trials for Cyclophosphamide (DB00531)

Back to Ovarian Endometrioid Adenocarcinoma
IndicationStatusPhase
DBCOND0028505 (Ovarian Endometrioid Adenocarcinoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02853318Pembrolizumab, Bevacizumab, and Cyclophosphamide in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerTreatment